In Memoriam: Rachna Shroff, MD, MS, FASCO: A Life Dedicated to Advancing Cancer Care
RYZ101 Improves PFS in Phase 3 ACTION-1 Trial for GEP-NETs After Lutetium-177 Therapy
Advanced Bladder Cancer: How Is First-Line Treatment Changing?
Unresectable Stage III NSCLC: PACIFIC Remains the Backbone as Precision Strategies Reshape Care
Secure Your Place at the European Cancer Summit and Help Shape the Future of Cancer Research - ECO
IARC Director Elisabete Weiderpass to Discuss How to Turn Cancer Research Into Action at Momentum 2026
NRG-BR002: Metastasis-Directed Ablation Fails to Improve PFS or OS in Oligometastatic Breast Cancer
Merck at ESMO 2026: Phase 3 mRNA, TROP2 ADC and Pembrolizumab Data Lead 90+ Abstracts
